Lumigan Side Effects Center

Last updated on RxList: 8/23/2022
Lumigan Side Effects Center

What Is Lumigan?

Lumigan (bimatoprost ophthalmic solution) is a synthetic prostamide analog with ocular hypotensive activity that works by regulating the flow of fluid within the eye to maintain a normal pressure used to treat certain types of glaucoma and other causes of high pressure inside the eye. Lumigan is also used to improve fullness, length, and color of the eyelashes in people with a condition called hypotrichosis, a lack of eyelash growth.

What Are Side Effects of Lumigan?

Common side effects of Lumigan include:

  • burning/stinging/irritation/ redness/discomfort of the eye,
  • feeling as if something is in your eye,
  • dry eyes,
  • watering eyes,
  • temporary unstable vision,
  • dizziness.

Long-term use (months to years) of Lumigan may cause brown discoloration of the colored portion of the eye (iris). Tell your doctor if you have unlikely but serious side effects of Lumigan including:

  • vision changes,
  • pain, redness, itching, or swelling in or around the eye,
  • swelling or redness of the eyelids,
  • oozing or discharge from your eye,
  • increased sensitivity to light, and
  • vision changes.

Lumigan may cause serious side effects including:

  • eye swelling,
  • redness of the eye,
  • severe discomfort in the eye,
  • crusting or drainage from the eye,
  • vision changes, and
  • red, swollen or itchy eyelids

Get medical help right away, if you have any of the symptoms listed above.

Seek medical care or call 911 at once if you have the following serious side effects:

  • Serious eye symptoms such as sudden vision loss, blurred vision, tunnel vision, eye pain or swelling, or seeing halos around lights;
  • Serious heart symptoms such as fast, irregular, or pounding heartbeats; fluttering in your chest; shortness of breath; and sudden dizziness, lightheartedness, or passing out;
  • Severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination, feeling unsteady, very stiff muscles, high fever, profuse sweating, or tremors.

This document does not contain all possible side effects and others may occur. Check with your physician for additional information about side effects.

Dosage for Lumigan

The recommended dose of Lumigan is one drop in the affected eye(s) once daily in the evening.

What Drugs, Substances, or Supplements Interact with Lumigan?

There may be other drugs that can interact with Lumigan.

Lumigan During Pregnancy and Breastfeeding

Tell your doctor about all prescription and over-the-counter medications you use, including vitamins, minerals, herbal products, and drugs prescribed by other doctors. Lumigan should be used only when prescribed by a doctor during pregnancy. Discuss the risks and benefits with your doctor. It is not known whether this drug passes into breast milk. Consult your doctor before breastfeeding.

Additional Information

Our Lumigan Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


Pink Eye (Conjunctivitis) Symptoms, Causes, Treatments See Slideshow
Lumigan Consumer Information

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using this medicine and call your doctor at once if you have:

  • eye swelling, redness, severe discomfort, crusting or drainage (may be signs of infection);
  • vision changes; or
  • red, swollen, or itchy eyelids.

Common side effects may include:

  • eye redness.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What causes dry eyes? See Answer
Lumigan Professional Information


The following adverse reactions are described elsewhere in the labeling:

  • Pigmentation including blepharal pigmentation and iris hyperpigmentation [see WARNINGS AND PRECAUTIONS]
  • Eyelash Changes [see WARNINGS AND PRECAUTIONS]
  • Intraocular Inflammation [see WARNINGS AND PRECAUTIONS]
  • Macular Edema [see WARNINGS AND PRECAUTIONS]
  • Hypersensitivity [see CONTRAINDICATIONS]

Clinical Trials Experience

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

In a 12-month clinical study with bimatoprost ophthalmic solutions 0.01%, the most common adverse reaction was conjunctival hyperemia (31%). Approximately 1.6% of patients discontinued therapy due to conjunctival hyperemia. Other adverse drug reactions (reported in 1 to 4% of patients) with LUMIGAN® 0.01% in this study included conjunctival edema, conjunctival hemorrhage, eye irritation, eye pain, eye pruritus, erythema of eyelid, eyelids pruritus, growth of eyelashes, hypertrichosis, instillation site irritation, punctate keratitis, skin hyperpigmentation, vision blurred, and visual acuity reduced.

Postmarketing Experience

The following adverse reactions have been identified during postapproval use of LUMIGAN® 0.01%. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. These reactions, which have been chosen for inclusion due to either their seriousness, frequency of reporting, possible causal connection to LUMIGAN®, or a combination of these factors include: asthma-like symptoms, dizziness, dry eye, dyspnea, eye discharge, eye edema, foreign body sensation, headache, hypersensitivity including signs and symptoms of eye allergy and allergic dermatitis, hypertension, lacrimation increased, periorbital and lid changes including deepening of the eyelid sulcus, and photophobia.

Read the entire FDA prescribing information for Lumigan (Bimatoprost Ophthalmic Solution 0.03% for Glaucoma)

© Lumigan Patient Information is supplied by Cerner Multum, Inc. and Lumigan Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors